PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/1873/8/06
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK TORCH study
During PMCPA scrutiny, a paid-for journal advertisement in Hospital Doctor (20 April; ref SFC/AVL/06/24428/1) promoted awareness of the TORCH (Towards a revolution in COPD health) study.The TORCH s…
🔒 Subscribers only
AUTH/1872/7/06
Data & Publications Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Shire
A hospital chief pharmacist alleged Shire was still using a “paper on taste” to promote Calcichew-D3 Forte, despite a prior ruling (AUTH/1825/4/06) that an advertisement referencing the paper w…
Clauses: NONE
🔒 Subscribers only
AUTH/1869/7/06
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
A Primary Care Trust chief pharmacist complained about three spreadsheets left/provided to a GP practice following a representative’s call.The spreadsheets were handwritten-titled “Cozaar”, �…
Clauses: NONE
🔒 Subscribers only
AUTH/1807/3/06
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer
A Sunday Times article (“Nurses earn bonuses for use of latest drugs”, 3 March 2006) alleged Pfizer paid nurses via an agency to run free audits in GP surgeries and that nurses could “influen…
Clauses: NONE
🔒 Subscribers only
AUTH/1866/7/06
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo voluntary admission after withdrawn Olmetec advert reappeared (breach of undertaking)
Daiichi-Sankyo (formerly Sankyo) voluntarily told the PMCPA that an Olmetec advertisement (OLM 188.1B) previously ruled in breach (AUTH/1787/12/05) had reappeared.The company had given an undertaki…
Clauses: 9.1
🔒 Subscribers only
AUTH/1863/7/06
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sanofi
The Observer ran an article (“Cancer drug firm’s PR trip sparks a row”) criticising a Sanofi-Aventis organised trip (1–3 July 2006) to Budapest and Paris involving heads of cancer charities…
Clauses: NONE
🔒 Subscribers only
AUTH/1854/6/06
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Servier
A principal hospital pharmacist complained that a journal advertisement for Coversyl (perindopril) (ref 06COAD339) had been used again despite a previous ruling against a similar ad (Case AUTH/1756…
Clauses: NONE
🔒 Subscribers only
AUTH/1852/6/06
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer
A general practitioner complained that Pfizer’s electronic response in the BMJ’s ‘Rapid Responses’ to an editorial (‘Switching statins’) was disguised promotion of Lipitor (atorvastatin…
Clauses: NONE
🔒 Subscribers only
AUTH/1851/6/06
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Roche v Novartis
Roche complained about Novartis’ promotion of Myfortic (mycophenolate sodium); Roche supplied CellCept (mycophenolate mofetil).At the British Society for Transplantation meeting (Edinburgh, 29–…
Clauses: NONE
🔒 Subscribers only
AUTH/1850/6/06
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Novartis
A Financial Times article (20 June 2006) claimed two pharma companies (including Novartis) were delaying disclosure of patient groups they funded for up to 18 months after a new Code requirement.Th…
Clauses: NONE
🔒 Subscribers only
AUTH/1745/7/05
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Abbott
The Sun ran an article (8 February) about an ex-Abbott employee and an employment tribunal, stating Abbott representatives attended a gay bar/club in Glasgow with at least one hospital consultant.T…
Clauses: NONE
🔒 Subscribers only
AUTH/1714/5/05
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
The MHRA forwarded a complaint from an ex-employee about representative call-frequency targets linked to promotion of Casodex (bicalutamide).Evidence included an AstraZeneca oncology sales/marketin…
Clauses: NONE
🔒 Subscribers only
AUTH/3824/09/2023
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
A GP complained about calls to their practice that appeared to be from NHS sources but were actually from pharma marketing teams; the latest call was said to be from Novartis.The GP alleged the cal…
Clauses: NONE
🔒 Subscribers only
AUTH/2198/10/9
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Solvay
A complaint was made by a Primary Care Trust against Solvay (case reference AUTH/2198/10/9).Further details of the allegation(s) are Not stated in the provided case text.
Clauses: NONE
🔒 Subscribers only
AUTH/3208/6/19
Social Media & Digital Breach 🏥 Dermatology ▶ Video 🎙 Podcast
Merz — Bocouture (botulinum toxin type A)
A Merz representative used an Instagram account set up under the company name to post content that included a Bocouture pack shot. The Panel ruled this constituted advertising a prescription-only m…
Clauses: 26.1,15.2,9.1
🔒 Subscribers only
AUTH/3248/9/19
Social Media & Digital Breach 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca — Forxiga (dapagliflozin), Lynparza (olaparib)
AstraZeneca voluntarily admitted that a UK-based employee retweeted nine tweets about Forxiga relating to unpublished DAPA-HF heart failure data (outside the licensed indication) from a personal Tw…
Clauses: 3.2,26.1,14.3
🔒 Subscribers only
AUTH/3287/12/19
Off-label Promotion Breach 🏥 Dermatology ▶ Video 🎙 Podcast
UCB — Bimekizumab (unlicensed)
A UCB employee's openly accessible personal LinkedIn profile described their role supporting a Phase 3 programme for bimekizumab, an unlicensed medicine, in a way that could generate pre-licen…
Clauses: 3.1,26.1,14.3
🔒 Subscribers only
AUTH/3239/8/19
Off-label Promotion Breach 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Colonis Pharma — Melatonin 1mg/ml Oral Solution
A promotional letter mailed to 18,649 recipients promoted Melatonin Oral Solution primarily for paediatric sleep disorders despite the licence being restricted to short-term treatment of jet-lag in…
Clauses: 3.2,7.2,9.1
🔒 Subscribers only
AUTH/3008/1/18
HCP Hospitality & Meetings Breach 🏥 Other ▶ Video 🎙 Podcast
Pharmasure — Pharmasure fertility products
A Pharmasure representative interrupted a competitor's clinical meeting at a private hospital to deliver a substantial high street chocolate hamper to a fertility centre team as a Christmas gi…
Clauses: 18.1,9.1,2
🔒 Subscribers only
AUTH/2118/4/08
Patient Organisations Breach 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim — Pradaxa (dabigatran etexilate)
A press release about Pradaxa issued by a Boehringer Ingelheim media advisor appeared to originate from Lifeblood: The Thrombosis Charity — without the charity being given sight of it, asked to c…
Clauses: 11.2,11.3,2
🔒 Subscribers only
AUTH/2257/8/09
Patient Organisations Breach 🏥 Oncology ▶ Video 🎙 Podcast
Ferring — Firmagon (degarelix)
Ferring's PR agency sent an unapproved and misleadingly edited version of a press release about Firmagon to a patient organisation, which then used it to create website content. The edited cop…
Clauses: 2,9.1,14.3,22.2,23.6
🔒 Subscribers only
AUTH/3027/3/18
Data & Publications Breach 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion — Latuda (lurasidone)
Sunovion voluntarily admitted it had told the PMCPA it had not worked with any patient organisations — which was incorrect. In 2016 it had made payments totalling over £12,000 to a mental health…
Clauses: 27.7,9.1
🔒 Subscribers only
AUTH/2163/8/08
Patient Organisations Breach 🏥 Other ▶ Video 🎙 Podcast
Eli Lilly — Cialis (tadalafil)
Consumers International complained that Lilly's 40over40.com erectile dysfunction disease awareness website and TV campaign effectively promoted Cialis to the public by including a comparative…
Clauses: 22.1,22.2
🔒 Subscribers only
AUTH/2154/8/08
Data & Publications Breach 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Roche / Chugai — Tocilizumab (RoActemra)
Roche and Chugai voluntarily admitted that a media release about new tocilizumab EULAR data contained headline claims describing tocilizumab as the "first and only" biologic to show super…
Clauses: 20.2,9.1
← Prev 70 71 72 73 Page 73 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews